register

News & Trends - Pharmaceuticals

De Castro takes the helm of J&J Innovative Medicine ANZ as Voegeli heads to European leadership role

Health Industry Hub | June 7, 2024 |

Pharma News: Johnson & Johnson has announced the appointment of Joana De Castro as the new Managing Director for Australia and New Zealand. De Castro will take over from Urs Voegeli, who has been named the new Managing Director of Johnson & Johnson Innovative Medicine in Germany, the second largest market for the company.

Prior to this new role, De Castro served as the Managing Director for Latin America North, where she led the business to historic growth and secured the #1 market position in each of J&J’s key therapeutic areas.

De Castro began her career with J&J in 2011 as a pharmaceutical sales representative in Venezuela, which she describes as an opportunity to “see first-hand the impact J&J has on patients.” She has since held multiple roles in the healthcare sector, gaining extensive regional and local experience across different countries.

Cyril Titeux, Company Group Chairman, Asia Pacific, stated “It was important to ensure a seamless leadership transition in a market as critical as ANZ, and we look forward to welcoming Joana to the Asia Pacific region.”

He further expressed confidence in De Castro’s expertise, stating, “Joana will lead the ANZ team in accelerating patient access to our transformational innovations, developing our world-class talent, and ultimately delivering sustainable business growth and a healthier future for patients.”

Under Voegeli’s leadership, the ANZ team fortified their market-leading revenue position in Australia. This was accomplished through a combination of exceptional customer execution and robust product access and reimbursement outcomes, according to the company. The #1 ranking was initially achieved in late 2022 and has since been solidified under Voegeli’s tenure.

In addition, Adam Wyldeck, Head of Communications & Public Affairs at Johnson & Johnson Innovative Medicine ANZ, has taken on the international role leading communications and public affairs for the US oncology business, which is the #1 market for the company. Wyldeck will be working closely with former ANZ boss Biljana Naumovic who is the Worldwide Vice President of Global Commercial Strategy Oncology, in addition to Tyrone Brewer, President of US Oncology.

“The US Oncology business is very much the jewel in the J&J crown. We have an incredible portfolio across haematology and solid tumours and an even more exciting pipeline. I feel humbled to be given the opportunity to lead communications and public affairs for such an important part of the company and I am excited to get stuck into it,” Wyldeck told Health Industry Hub.

He added, “I’m also extremely proud of the work we have done in ANZ over the last three years and the team I have built. They are the best team in the industry and are well positioned to deliver award winning work on behalf of the business and for patients.”

Reflecting on the leadership changes, Titeux remarked, “The transition of these roles is a part of J&J’s commitment to developing global leaders that excel across the world stage.”

The leadership changes are due to take place in August, pending visa approval.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.